𝔖 Bobbio Scriptorium
✦   LIBER   ✦

One-year follow-up of patients with acromegaly treated with fixed or titrated doses of lanreotide Autogel®

✍ Scribed by Ph. Caron; M. Bex; D. R. Cullen; U. Feldt-Rasmussen; A. M. Pico Alfonso; S. Pynka; K. Racz; J. Schopohl; A. Tabarin; M. J. Valimaki; The Group for Lanreotide Autogel® Long-Term Study on Acromegaly

Book ID
108702948
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
252 KB
Volume
60
Category
Article
ISSN
0300-0664

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic factors for patients with col
Prognostic factors for patients with colon or rectal carcinoma treated with resection only: Five-year follow-up report
✍ Takeshi Tominaga; Takashi Sakabe; Yasuo Koyama; Kyoichi Hamano; Masayuki Yasutom 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB 👁 2 views

## BACKGROUND. The prognostic factors and natural history of recurrence in patients with colorectal carcinoma who underwent curative resection and no other therapy were analyzed. METHODS. The object of analysis was the potentially curative resection only subgroup in the randomized clinical trial (R

Biochemical and virological outcome of p
Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: A 4-year follow-up of 211 patients
✍ E K Manesis; C Papaioannou; A Gioustozi; G Kafiri; J Koskinas; S J Hadziyannis 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB 👁 2 views

To compare two interferon (IFN) schedules for the treatment of chronic hepatitis C, we followed 211 patients who received 3 million units IFN-alpha2b thrice weekly for either 6 months (group 1; 85 patients) or 12 months (group 2; 126 patients), with a median follow-up of 3.4 (0.1-8.4) and 4.2 (0.7-8